Indeed, prescribing effective diabetes medications, with additional cardiovascular benefits, represents a key objective of pharmaceutical care plans for many T2DM patients.26 The beneficial effects of apelin on the cardiovascular system are relatively well studied,27,28 whereas positive actions in diabetes less advanced. The gene discussed is APLN; the disease is diabetes mellitus.